Is this your brand? Sign in to claim ownership.
Sign in to claim this brandATRICURE, INC.
United States·US-MF-000002974
Last updated September 17, 2026
Information
- Country
- United States
- Address
- 7555, Innovation Way, Mason, United States
- Website
- www.atricure.com
- —
- —
- [email protected]
- Phone
- 866-349-2342
- PRRC Contact
- Scott Ehlert
- EUDAMED SRN
- US-MF-000002974
- FDA FEI Number
- 3011706110
- DUNS Number
- 006133784
Catalogue (441)
Page 3 of 9| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| LiV™ Instruments | 001-340-7802L | FDA UDI | Class I | Active |
| cryoICE Cryoablation System | ACM | FDA UDI | Class II | Active |
| Subtle Cannula with Guide | CSK-6130 | FDA UDI | Class I | Active |
| AtriClip™ LAA Exclusion System | ACH150 | FDA UDI | Class II | Active |
| LiV™ Instruments | 001-340-7831S | FDA UDI | Class I | Active |
| LiV™ Instruments | 001-340-7498 | FDA UDI | Class I | Active |
| AtriClip™ LAA Exclusion System | PRO140 | FDA UDI | Class II | Active |
| AtriClip™ LAA Exclusion System | ACH135 | FDA UDI | Class II | Active |
| Isolator Surgical Ablation System | GPT100 | FDA UDI | Class I | Active |
| AtriClip™ LAA Exclusion System | LAA035 | FDA UDI | Class II | Active |
| AtriClip™ LAA Exclusion System | ACH145 | FDA UDI | Class II | Active |
| SofTIP | 60-02 | FDA UDI | Class II | Active |
| AtriClip® LAA Exclusion System | PRO250 | FDA UDI | Class II | Active |
| AtriCure SI Retractor Blade | 001-400-181 | FDA UDI | Class I | Active |
| LiV™ Instruments | 001-340-7470 | FDA UDI | Class I | Active |
| EPi-Sense Guided Coagulation System with VisiTrax | CSK-2000 | FDA UDI | Class II | Active |
| AtriCure cryoICE Cryoablation System (CRYO2) | CRYO2 | FDA UDI | Class II | Active |
| AtriCure cryoICE cryoSPHERE+ Cryoablation System | CRYOSP | FDA UDI | Class II | Active |
| LiV™ Instruments | 001-340-7821L | FDA UDI | Class I | Active |
| AtriCure System Cart | ASCO | FDA UDI | Class I | Active |
| LiV™ Instruments | 001-340-7803L | FDA UDI | Class I | Active |
| Fusion Ablation System | 001-700-002 | FDA UDI | Class II | Active |
| AtriCure Atrial Lift System | 001-401-503 | FDA UDI | Class I | Active |
| cryoICE Cryoablation System | CRYOF | FDA UDI | Class II | Active |
| AtriClip® LAA Exclusion System | PRO235 | FDA UDI | Class II | Active |
| AtriCure Aortic Valve Assistant | 001-400-451 | FDA UDI | Class I | Active |
| Synergy™ Ablation System | OLL2 | FDA UDI | Class III | Active |
| AtriCure Isolator Synergy EnCompass Clamp and Guide System | OSH | FDA UDI | Class II | Active |
| AtriClip™ LAA Exclusion System | ACH145 | FDA UDI | Class II | Active |
| AtriClip™ LAA Exclusion System | ACH245 | FDA UDI | Class II | Active |
| cryoICE Cryoablation System | ACM1 | FDA UDI | Class II | Active |
| AtriClip FLEX•V | ACHV45 | FDA UDI | Class II | Active |
| TenSURE | 7 lb | FDA UDI | Class I | Active |
| Dissector | MID1 | FDA UDI | Class I | Active |
| AtriCure Isolator Synergy EnCapture Clamp | EMH | FDA UDI | Class II | Active |
| Lariat RS | 30-06 | FDA UDI | Class II | Active |
| AtriCure Atrial Rake | 001-400-443 | FDA UDI | Class I | Active |
| AtriClip™ LAA Exclusion System | ACH235 | FDA UDI | Class II | Active |
| AtriCure System Cart | ASCC-400 | FDA UDI | Class I | Active |
| AtriCure cryoICE Cryoablation System (CRYO2) | CRYO2 | FDA UDI | Class II | Active |
| LiV™ Instruments | 001-340-7484 | FDA UDI | Class I | Active |
| nContact RF Generator | CSK-320 | FDA UDI | Class II | Active |
| AtriCure System Cart | ASCC2 | FDA UDI | Class I | Active |
| AtriCure Aortic Valve Assistant | 001-400-453 | FDA UDI | Class I | Active |
| AtriClip® PRO•V™ LAA Exclusion System | PROV50 | FDA UDI | Class II | Active |
| Lariat RS | 30-06 | FDA UDI | Class II | Active |
| AtriClip® Gillinov-Cosgrove® LAA Exclusion System | ACH150 | FDA UDI | Class II | Active |
| AtriCure cryoICE cryoFORM Cryoablation System (CRYOF) | CRYOF | FDA UDI | Class II | Active |
| Dissector | GPD1 | FDA UDI | Class I | Active |
| AtriClip® LAA Exclusion System | CGG | FDA UDI | Class I | Active |
Related Companies
Authorised Representatives
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (13)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Nov 28, 2023 | Z-0927-2024 | — | open, classified | AtriCure has identified certain lots of tank hose assemblies where a second-tier supplier provided incorrect tank hose assemblies. These tank hose assemblies were provided with an outer sheathing that does not have required pin perforations and the inner tube of the hose is not the correct material. |
| Nov 28, 2023 | Z-0928-2024 | — | open, classified | AtriCure has identified certain lots of tank hose assemblies where a second-tier supplier provided incorrect tank hose assemblies. These tank hose assemblies were provided with an outer sheathing that does not have required pin perforations and the inner tube of the hose is not the correct material. |
| May 29, 2019 | Z-1887-2019 | — | terminated | The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used. |
| Jan 22, 2019 | Z-0831-2019 | — | terminated | There is a potential for patients undergoing ablation to experience an elevated risk for TE; during stand-alone off-pump procedures where cardio pulmonary bypass (CPB) was not utilized. |
| Jan 22, 2019 | Z-0830-2019 | — | terminated | There is a potential for patients undergoing ablation to experience an elevated risk for TE; during stand-alone off-pump procedures where cardio pulmonary bypass (CPB) was not utilized. |
| Jan 22, 2019 | Z-0832-2019 | — | terminated | There is a potential for patients undergoing ablation to experience an elevated risk for TE; during stand-alone off-pump procedures where cardio pulmonary bypass (CPB) was not utilized. |
| Jan 22, 2019 | Z-0829-2019 | — | terminated | There is a potential for patients undergoing ablation to experience an elevated risk for TE; during stand-alone off-pump procedures where cardio pulmonary bypass (CPB) was not utilized. |
| Nov 30, 2016 | Z-1148-2017 | — | terminated | A complaint of the PRO2 jaw breaking prior to surgery being performed. |
| Sep 22, 2016 | Z-0377-2017 | — | terminated | There is a potential for a component failure of the device which could necessitate medical intervention. |
| Sep 22, 2016 | Z-0653-2017 | — | terminated | Due to product design and process control, part of the device can separate and remain behind when the device is removed that can potentially cause permanent impairment or damage to body function or structure. |
| Nov 21, 2014 | Z-0895-2015 | — | terminated | Affected product may have compromised sterility due to packaging defects. It was determined that some mishandling of the product during the packaging process could inadvertently damage the sterile barrier. |
| Jan 23, 2014 | Z-1209-2014 | — | terminated | The firm was notified by a customer of a cracked spring in the handle of the RCD1 device. |
| Jan 14, 2013 | Z-0912-2013 | — | terminated | Products from lot no. 41865 may have been sent out with Incorrect Instructions for Use (IFU) labeling. |